Human Genome Epidemiology Literature Finder
|
Records 1 - 28 (of 28 Records) |
| Query Trace: Lung Neoplasms and CYP1B1[original query] |
|---|
| CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005 Dec 26 (12): 2207-12. Wenzlaff A S, Cote M L, Bock C H, Land S J, Santer S K, Schwartz D R, Schwartz A |
| Characterization of common CYP1B1 variants with different capacity for benzo[a]pyrene-7,8-dihydrodiol epoxide formation from benzo[a]pyrene. Cancer research 2005 Jun 65 (12): 5105-11. Aklillu Eleni, Øvrebø Steinar, Botnen Ingrid V, Otter Charlotta, Ingelman-Sundberg Magn |
| Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer letters 2005 Jun 223 (2): 265-74. Liang Geyu, Pu Yuepu, Yin Liho |
| Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer letters 2005 Apr 221 (2): 185-90. Sørensen Mette, Autrup Herman, Tjønneland Anne, Overvad Kim, Raaschou-Nielsen O |
| Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Lung cancer (Amsterdam, Netherlands) 2007 Mar 55 (3): 255-62. Cote M L, Wenzlaff A S, Bock C H, Land S J, Santer S K, Schwartz D R, Schwartz A |
| Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007 Jul 18 (7): 1230-42. Vineis P, Veglia F, Garte S, Malaveille C, Matullo G, Dunning A, Peluso M, Airoldi L, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J P, Kaaks R, Boeing H, Trichopoulou A, Palli D, Crosignani P, Tumino R, Panico S, Bueno-De-Mesquita H B, Peeters P H, Lund E, Gonzalez C A, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros J R, Berglund G, Jarvholm B, Day N E, Key T J, Saracci R, Riboli E, Autrup |
| CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung cancer (Amsterdam, Netherlands) 2008 Apr 60 (1): 40-6. Yoon Kyong-Ah, Kim Jin Hee, Gil Hyea-Jin, Hwang Hyukkee, Hwangbo Bin, Lee Jin S |
| Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer. Mutation research 2008 Aug 643 (1-2): 4-10. Shah Parag P, Singh Arvind P, Singh Madhu, Mathur Neeraj, Mishra Bhartendu N, Pant Mohan C, Parmar Devend |
| A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 2008 Jun 29 (6): 1164-9. Zienolddiny Shanbeh, Campa Daniele, Lind Helge, Ryberg David, Skaug Vidar, Stangeland Lodve B, Canzian Federico, Haugen Aa |
| CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis 2009 Jul 30 (7): 1161-9. Timofeeva Maria N, Kropp Silke, Sauter Wiebke, Beckmann Lars, Rosenberger Albert, Illig Thomas, Jäger Birgit, Mittelstrass Kirstin, Dienemann Hendrik, , Bartsch Helmut, Bickeböller Heike, Chang-Claude Jenny C, Risch Angela, Wichmann Heinz-Eri |
| Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PloS one 2009 4 (5): e5652. Rotunno Melissa, Yu Kai, Lubin Jay H, Consonni Dario, Pesatori Angela C, Goldstein Alisa M, Goldin Lynn R, Wacholder Sholom, Welch Robert, Burdette Laurie, Chanock Stephen J, Bertazzi Pier Alberto, Tucker Margaret A, Caporaso Neil E, Chatterjee Nilanjan, Bergen Andrew W, Landi Maria Tere |
| Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 2009 Apr 30 (4): 626-35. Cote Michele L, Yoo Wonsuk, Wenzlaff Angela S, Prysak Geoffrey M, Santer Susan K, Claeys Gina B, Van Dyke Alison L, Land Susan J, Schwartz Ann |
| CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients. Neoplasma 2010 57 (6): 512-21. Ada A O, C Kunak S, Hancer F, Bilgen S, Suzen S H, Alpar S, Gulhan M, Kurt B, Iscan |
| The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects. Lung cancer (Amsterdam, Netherlands) 2010 Dec 70 (3): 247-52. Chen Bo, Qiu Li-Xin, Li Yan, Xu Wei, Wang Xue-Li, Zhao Wei-Hong, Wu Jian-Qi |
| Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis. Molecular biology reports 2012 Mar 39 (3): 2821-9. Xu Wenhuan, Zhou Yunhai, Hang Xiaosheng, Shen |
| Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis. Lung 2014 Oct 192 (5): 739-48. Lao Xianjun, Qin Xue, Peng Qiliu, Chen Zhiping, Lu Yu, Liu Yanqiong, Li Sh |
| Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis. Molecular genetics and genomics : MGG 2015 Apr 290 (2): 739-65. Liu Jie-Ying, Yang Yu, Liu Zhi-Zhong, Xie Jian-Jun, Du Ya-Ping, Wang W |
| Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients. Journal of cancer research and clinical oncology 2015 Jul 141 (7): 1189-94. Vasile Enrico, Tibaldi Carmelo, Leon G Leticia, D'Incecco Armida, Giovannetti Eli |
| Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis. Technology in cancer research & treatment 2015 Aug . Chen Pei-Fen, He Xiao-Feng, Huang Guo-Hua, Wang Wei, Qiu Zhi-H |
| Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers. Current drug metabolism 2015 16 (10): 850-63. He Xin, Feng Sh |
| Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients. Turkish journal of medical sciences 2017 Apr 47 (2): 554-562. Karacao?lan Volkan, Ada Ahmet O?uz, Bilgen Serdar, Çetinkaya Guzide Tu?ba, Soyda? Emre, Kunak Celalettin Semih, Alpar Sibel Meryem, Gülhan Meral, I?can Mümt |
| Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies. Lung cancer (Amsterdam, Netherlands) 2017 11 113 18-29. Liu Caiyang, Cui Huijie, Gu Dongqing, Zhang Min, Fang Yanfei, Chen Siyu, Tang Mingshuang, Zhang Ben, Chen Huanw |
| Relationship between CYP1B1 polymorphisms (c.142C > G, c.355G > T, c.1294C > G) and lung cancer risk in Polish smokers. Future oncology (London, England) 2018 Jun . Sawrycki Piotr, Domagalski Krzysztof, Cechowska Magdalena, G?sior Marcin, Jarkiewicz-Tretyn Joanna, Tretyn Andrz |
| Cytochrome P-450 Polymorphisms and Clinical Outcome in Patients with Non-Small Cell Lung Cancer. Turkish journal of pharmaceutical sciences 2020 5 14 (3): 319-323. I?can Mümtaz, Ada Ahmet O? |
| Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. The pharmacogenomics journal 2021 3 21 (3): 336-345. van Eijk Maarten, Pluim Dick, Dorlo Thomas P C, Marchetti Serena, Huitema Alwin D R, Beijnen Jos |
| Retracted: Medical Data Analysis of CYP1B1 Gene Polymorphism and Clinical Prognosis of Minimally Invasive Surgery for Lung Cancer. BioMed research international 2023 12 2023 9819417. BioMed Research Internation |
| Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image. Open life sciences 2023 10 18 (1): 20220688. Shaofeng Zhang, Danqing Li, Xia H |
| Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model. Open life sciences 2023 10 18 (1): 20220705. Bo Liu, Shaofeng Zhang, Chunyan Liu, Xia H |
- Page last reviewed:Feb 1, 2024
- Content source: